CD44+CD24low+-initiated tumours grew more rapidly than those from CD44+CD24neg cells (data for MDA-MB-231 10,000 cell injections, Fig 3D; data for DT-22 100,000 cell injections, Fig 6G). The gene discussed is CD44; the disease is neoplasm.